Mapping the intellectual structure and landscape of colorectal cancer immunotherapy: A bibliometric analysis
- PMID: 38497584
- PMCID: PMC10950274
- DOI: 10.1080/21645515.2024.2323861
Mapping the intellectual structure and landscape of colorectal cancer immunotherapy: A bibliometric analysis
Abstract
Immunotherapy, particularly immune checkpoint inhibitor (ICIs) therapy, stands as an innovative therapeutic approach currently garnering substantial attention in cancer treatment. It has become a focal point of numerous studies, showcasing significant potential in treating malignancies, including lung cancer and melanoma. The objective of this research is to analyze publications regarding immunotherapy for colorectal cancer (CRC), investigating their attributes and identifying the current areas of interest and cutting-edge advancements. We took into account the publications from 2002 to 2022 included in the Web of Science Core Collection. Bibliometric analysis and visualization were conducted using CiteSpace, VOSviewer, R-bibliometrix, and Microsoft Excel. The quantity of publications associated with this domain has been steadily rising over the years, encompassing 3753 articles and 1498 reviews originating from 573 countries and regions, involving 19,166 institutions, 1011 journals, and 32,301 authors. In this field, China, the United States, and Italy are the main countries that come forward for publishing. The journal with the greatest impact factor is CA-A Cancer Journal for Clinicians. Romain Cohen leads in the number of publications, while Le Dt stands out as the most influential author. The immune microenvironment and immune infiltration are emerging as key hotspots and future research directions in this domain. This research carries out an extensive bibliometric examination of immunotherapy for colorectal cancer, aiding researchers in understanding current focal points, investigating possible avenues for research, and recognizing forthcoming development trends.
Keywords: CiteSpace; Colorectal cancer; VOSviewer; bibliometric study; immunotherapy; research trends.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures







Similar articles
-
Current perspectives and trends of CD39-CD73-eAdo/A2aR research in tumor microenvironment: a bibliometric analysis.Front Immunol. 2024 Aug 12;15:1427380. doi: 10.3389/fimmu.2024.1427380. eCollection 2024. Front Immunol. 2024. PMID: 39188712 Free PMC article.
-
Insights into the historical trajectory and research trends of immune checkpoint blockade in colorectal cancer: visualization and bibliometric analysis.Front Immunol. 2024 Oct 31;15:1478773. doi: 10.3389/fimmu.2024.1478773. eCollection 2024. Front Immunol. 2024. PMID: 39544944 Free PMC article.
-
Visual Analysis of Colorectal Cancer Immunotherapy: A Bibliometric Analysis From 2012 to 2021.Front Immunol. 2022 Mar 31;13:843106. doi: 10.3389/fimmu.2022.843106. eCollection 2022. Front Immunol. 2022. PMID: 35432385 Free PMC article.
-
Bibliometric study of immunotherapy for hepatocellular carcinoma.Front Immunol. 2023 Aug 4;14:1210802. doi: 10.3389/fimmu.2023.1210802. eCollection 2023. Front Immunol. 2023. PMID: 37600802 Free PMC article. Review.
-
Research hotspots and frontiers in the tumor microenvironment of colorectal cancer: a bibliometric study from 2014 to 2024.Front Oncol. 2025 Feb 5;15:1525280. doi: 10.3389/fonc.2025.1525280. eCollection 2025. Front Oncol. 2025. PMID: 39975599 Free PMC article.
Cited by
-
Circ_RUSC2 Sequesters miR-661 and Elevates TUSC2 Expression to Suppress Colorectal Cancer Progression.Int J Mol Sci. 2025 Mar 24;26(7):2937. doi: 10.3390/ijms26072937. Int J Mol Sci. 2025. PMID: 40243558 Free PMC article.
-
Targeting tumor-infiltrating CCR8+ regulatory T cells induces antitumor immunity through functional restoration of CD4+ Tconvs and CD8+ T cells in colorectal cancer.J Transl Med. 2024 Jul 30;22(1):709. doi: 10.1186/s12967-024-05518-8. J Transl Med. 2024. PMID: 39080766 Free PMC article.
-
Neoadjuvant therapy for colorectal cancer from 2015 to 2024: a visual analysis and bibliometric analysis.Front Oncol. 2025 Apr 2;15:1526610. doi: 10.3389/fonc.2025.1526610. eCollection 2025. Front Oncol. 2025. PMID: 40242245 Free PMC article.
-
Research progress and trends in colorectal cancer self-management: a bibliometric analysis from 2004 to 2024.Support Care Cancer. 2025 Jun 24;33(7):620. doi: 10.1007/s00520-025-09678-1. Support Care Cancer. 2025. PMID: 40553222 Free PMC article.
References
-
- Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, Jemal A, Schymura MJ, Lansdorp-Vogelaar I, Seeff LC, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116(3):544–73. doi:10.1002/cncr.24760. - DOI - PMC - PubMed
-
- Sargent D, Sobrero A, Grothey A, O’Connell MJ, Buyse M, Andre T, Zheng Y, Green E, Labianca R, O’Callaghan C, et al. Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol. 2009;27(6):872–7. doi:10.1200/JCO.2008.19.5362. - DOI - PMC - PubMed
-
- Wei SC, Duffy CR, Allison JP. Fundamental mechanisms of immune checkpoint blockade therapy. Cancer Discov. 2018;8(9):1069–86. doi:10.1158/2159-8290.CD-18-0367. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical